CareDx CDNA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$8.19M-113% | -$21.35M-141% | $70.45M+146% | $58.14M+135% | $62.08M+133% | ||
| $15.32M+9.6% | $15.02M+5.8% | $14.5M+0.2% | $14.15M-3.4% | $13.97M-5.5% | ||
| $35.74M-39.2% | $34.86M-47.5% | $43.28M-27.7% | $51.79M-6.9% | $58.76M+13.2% | ||
| $72.95M+172% | $42.03M+10.5% | $42.56M+447% | $17.72M+219% | $26.78M+178% | ||
| —— | —— | —— | —— | $2.1M+227% | ||
| —— | —— | $34.96M— | —— | —— | ||
| -$95.66M— | -$93.39M— | -$81.84M— | —— | —— | ||
| —— | —— | —— | -$27.23M— | -$4.21M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does CareDx generate?
- CareDx (CDNA) generated $72.9M in operating cash flow over the trailing twelve months.
- What is CareDx's free cash flow?
- After $5.8M of capital expenditures, CareDx's free cash flow was -$9.0M over the trailing twelve months, down 197.8% year over year.
- Where does CareDx's cash flow data come from?
- Every line is extracted from CareDx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
